Empatica Inc. is an MIT Media Lab spinoff company born in Cambridge, Massachusetts, operating in Healthcare, providing AI-enabled tools to advance forecasting, monitoring, research, and treatment. [1] Empatica produces medical-grade wearables, software and algorithms for the collection and interpretation of physiological data. [2] Empatica's wearables, Embrace2 and E4, track physiological signals such as Heart Rate Variability, electrodermal activity, acceleration and movement, skin temperature, and autonomic arousal. [3] Embrace2 has been cleared by the FDA as a seizure alerting solution for epilepsy patients with generalized tonic-clonic seizures. [4] The E4 is used by researchers for real-time physiological data capture. The company is headquartered in Boston, MA with offices in Milan, Italy, and Seoul, South Korea.[ citation needed ]
Type | Private |
---|---|
Industry | Healthcare |
Founder | Matteo Lai, Maurizio Garbarino, Rosalind Picard, Simone Tognetti |
Headquarters | Boston, Massachusetts |
Products | Embrace2, E4 Wristband, EmbracePlus, Research Portal, Alert App, Mate App, Aria, Empatica Care |
Services | Remote Health Monitoring, Clinical Trial Platforms Development, Respiratory Infections Detection, Seizure Monitoring, Biomarkers Development |
Website | https://www.empatica.com |
Empatica Inc. was founded in 2013 in Cambridge, Massachusetts, by Matteo Lai, Simone Tognetti, Maurizio Garbarino and Rosalind Picard. Picard serves as part-time chief scientist and chairman of the board, while Lai is full-time CEO, Tognetti is CTO, and Garbarino is CSA.
In 2014, in partnership with The Epilepsy Foundation, Empatica launched a crowdfunding campaign on Indiegogo for the creation of a wrist-worn device for monitoring and alerting to grand mal seizures, and help reduce cases of Sudden Unexpected Death in Epilepsy (SUDEP). [5] [6] This device was called Embrace.
In January 2018 Embrace (both the hardware and its Alert software) received FDA-clearance for adults and became the first medical wristwatch to be cleared by FDA for use in Epilepsy. [4] In November 2018 an updated version of the Embrace, called Embrace2, was released. [7]
In January 2019, Embrace2 received FDA-clearance for children ages 6 and up. [8]
In November 2022, the Empatica Health Monitoring Platform received FDA-clearance for continuous data collection to monitor SpO2, electrodermal activity, skin temperature, and activity associated with movement during sleep. [9]
The NASA-funded Translational Research Institute for Space Health (TRISH) is working with Empatica to develop a smartwatch able to monitor the health of the astronauts that will be on board the first crewed mission to Mars. [10]
Since 2018, Empatica has been working in partnership with the U.S. Government's BARDA Division of Research, Innovation and Ventures (DRIVe), under the Department of Health and Human Services (HHS), to collaborate on the development of a new smartwatch which will alert users when they are developing a serious respiratory infection before any symptoms appear. [11]
In response to the COVID-19 pandemic, Empatica is collaborating with the U.S. Army Medical Research and Development Command (USAMRDC) to deploy a wearable and algorithm that enables the early and pre-symptomatic detection of COVID-19. [12]
Empatica also partnered with Japanese multinational information and network technology company NEC in a health study to help Japanese employees measure their stress levels, as a response to the phenomenon of karoshi. [13]
Prescription digital therapeutics company Pear Therapeutics is collaborating with Empatica to use its wearable sensors to evaluate withdrawal symptoms in patients with substance use disorder (SUD), opioid use disorder (OUD), and alcohol use disorder (AUD). [14]
Embrace is a smartwatch designed to detect generalized tonic-clonic seizures and alert caregivers in real-time via a companion app Alert. [15] The idea for Embrace was born following a discovery developing sensors to monitor stress. Chief Scientist and co-founder Rosalind Picard and her colleagues at the MIT Media lab were initially working on a wristband to help children on the autism spectrum better communicate their emotional states. One of Picard's undergraduate students borrowed a couple of devices to bring home over the winter break and test them on his autistic brother. A spike in activity registered by one of the devices during this time, attributed to a grand mal seizure event, tipped Picard off to the technology's potential for seizure detection. [5] [16]
Embrace is also used by researchers, pharmaceutical businesses, and other healthcare investigators to collect medical quality data for research. In 2017, Sunovion used Embrace in a phase 4 clinical study of Aptiom, a drug meant to reduce seizures in people with epilepsy. [17] In 2018, results were published showing that data collected by Embrace was useful in examining the nausea felt by passengers undergoing zero-gravity flight. [18]
Alert is a mobile app and subscription service that works with Embrace2 to send out an emergency call and text message to listed caregivers, including their exact GPS location. [19]
Mate is a mobile app that displays physiological data collected by the Embrace2. It displays sleep time, efficiency, fragmentation, and tosses and turns, as well as levels of physical activity and step count. It can also be used as a digital seizure diary. [20]
The Research Portal is a cloud-based software that enables researchers to virtually view and process the raw data collected by Embrace during their studies.
The E4 collects real-time physiological data, which can be used to conduct in-depth analysis and visualization. [21] The device is equipped with a PPG sensor, EDA sensor, 3-axis accelerometer, and Infrared Thermopile. The E4 is used by researchers to measure arousal in individuals within laboratory and/or naturalistic settings to study, for example, stress or other emotions. [3] Studies conducted using the E4 range from testing wearables for predicting substance addiction relapses, [22] to measuring the engagement of students in a classroom, [23] to researching predictions in aggressive meltdowns in autism. [24]
In November 2019, Empatica announced EmbracePlus, [25] a research smart watch which is built in partnership with the Translational Research Institute for Space Health (TRISH), under NASA’s Human Research Program (HRP) which develops innovative approaches to reduce risks to humans on deep space missions, including NASA’s Journey to Mars. [26]
EmbracePlus is able to continuously and remotely collect and process key physiological signals from the wrist, including pulse rate, pulse rate variability, blood oxygenation, respiratory rate, skin temperature, electrodermal activity, rest, and actigraphy data. [27]
Following a response to the Request for Project Proposals issued in May 2020, Empatica has received funding from the U.S. Army Medical Research and Development Command to deploy EmbracePlus (and the Aria algorithm) to enable the early and pre-symptomatic detection of COVID-19. [28] The device will monitor a person’s vital signs, and check for patterns that suggest the presence of a COVID-19 infection. This can be used to help wearers self-isolate and seek testing without unwittingly infecting others.
In April 2021, EmbracePlus has received the European CE mark as a Class lla medical device. [29]
Aria was developed in response to COVID-19 and in partnership with the U.S. Department of Health and Human Services’ BARDA. [30] It is a wearable AI system with an app and online dashboard, that can help contain an infectious transmission by automatically alerting individuals to the earliest physiological signs of a possible infection, even without any symptoms being present. [31]
In November 2020 Empatica has received funding from the U.S. Army Medical Research and Development Command to deploy Aria (and the EmbracePlus smartwatch) to enable the early and pre-symptomatic detection of COVID-19. [28]
In March 2021, Aria has received the European CE mark for early detection of COVID-19. [32]
Empatica Care is an AI-powered platform that enables the continuous, remote monitoring of patients. The subject's physiological data are collected by the EmbracePlus smartwatch and communicated to the Care App via Bluetooth. The data transferred to the cloud by the wearable device is automatically gathered inside the Care Portal, an online tool where professionals can visualize in real-time vitals of individuals who may be at work, at home, or in a different ward inside the hospital. [33]
In March 2021, Care has received the European CE mark for early detection of COVID-19. [34]
Neuroimaging is the use of quantitative (computational) techniques to study the structure and function of the central nervous system, developed as an objective way of scientifically studying the healthy human brain in a non-invasive manner. Increasingly it is also being used for quantitative studies of brain disease and psychiatric illness. Neuroimaging is a highly multidisciplinary research field and is not a medical specialty.
Rosalind Wright Picard is an American scholar and inventor who is Professor of Media Arts and Sciences at MIT, founder and director of the Affective Computing Research Group at the MIT Media Lab, and co-founder of the startups Affectiva and Empatica.
A medical alarm is an alarm system designed to signal the presence of a hazard requiring urgent attention and to summon emergency medical personnel. Other terms for a medical alarm are Personal Emergency Response System (PERS) or medical alert. It is especially important to recognize the need to respond to situations where the person is unable to summon help.
Non-contact thermography, thermographic imaging, or medical thermology is the field of thermography that uses infrared images of the human skin to assist in the diagnosis and treatment of medical conditions. Medical thermology is sometimes referred to as medical infrared imaging or tele-thermology and utilizes thermographic cameras. According to the American Academy of Thermology, Medical Thermology practitioners are licensed health care practitioners who utilize IR imaging in consistent with medically established paradigms of care. Non-medically licensed alternative practitioners who are not held to the same standard may offer thermography services but that should not be confused with the field of medical thermology.
Responsive neurostimulation device is a medical device that senses changes in a person's body and uses neurostimulation to respond in the treatment of disease. The FDA has approved devices for use in the United States in the treatment of epileptic seizures and chronic pain conditions. Devices are being studied for use in the treatment of essential tremor, Parkinson's disease, Tourette's syndrome, depression, obesity, and post-traumatic stress disorder.
Fitbit is an American consumer electronics and fitness company. It produces wireless-enabled wearable technology, physical fitness monitors and activity trackers such as smartwatches, pedometers and monitors for heart rate, quality of sleep and stairs climbed as well as related software. The company was acquired by Google in January 2021.
Electroencephalography (EEG) is a method to record an electrogram of the spontaneous electrical activity of the brain. The biosignals detected by EEG have been shown to represent the postsynaptic potentials of pyramidal neurons in the neocortex and allocortex. It is typically non-invasive, with the EEG electrodes placed along the scalp using the International 10–20 system, or variations of it. Electrocorticography, involving surgical placement of electrodes, is sometimes called "intracranial EEG". Clinical interpretation of EEG recordings is most often performed by visual inspection of the tracing or quantitative EEG analysis.
Wearable technology is any technology that is designed to be used while worn. Common types of wearable technology include smartwatches and smartglasses. Wearable electronic devices are often close to or on the surface of the skin, where they detect, analyze, and transmit information such as vital signs, and/or ambient data and which allow in some cases immediate biofeedback to the wearer.
Withings is a French consumer electronics company headquartered in Issy-les-Moulineaux, France. It also has offices in Boston, Massachusetts, USA, and Hong Kong, and distributes its products worldwide. Withings is known for design and innovation in connected devices, such as the first Wi-Fi scale on the market, an FDA-cleared blood pressure monitor, a smart sleep system, and a line of automatic activity tracking watches. It also provides B2B solutions for healthcare providers and researchers.
In medicine, monitoring is the observation of a disease, condition or one or several medical parameters over time.
Remote patient monitoring (RPM) is a technology to enable monitoring of patients outside of conventional clinical settings, such as in the home or in a remote area, which may increase access to care and decrease healthcare delivery costs. RPM involves the constant remote care of patients by their physicians, often to track physical symptoms, chronic conditions, or post-hospitalization rehab.
Fitness to dive, specifically the medical fitness to dive, is the medical and physical suitability of a diver to function safely in the underwater environment using underwater diving equipment and procedures. Depending on the circumstances it may be established by a signed statement by the diver that they do not have any of the listed disqualifying conditions and is able to manage the ordinary physical requirements of diving, to a detailed medical examination by a physician registered as a medical examiner of divers following a procedural checklist, and a legal document of fitness to dive issued by the medical examiner.
An activity tracker, also known as a fitness tracker, is a device or application for monitoring and tracking fitness-related metrics such as distance walked or run, calorie consumption, and in some cases heartbeat. It is a type of wearable computer. The term is now primarily used for smartwatches that are synced, in many cases wirelessly, to a computer or smartphone for long-term data tracking. There are also independent mobile and Facebook apps. Some evidence has found that the use of these type of devices results in less weight loss rather than more. Sleep tracker devices have a tendency to underdetect wakefulness.
AliveCor is a medical device and AI company producing ECG hardware and software for consumer mobile devices. The company was the first to receive FDA-clearance for a medical-device accessory to the Apple Watch. The company's primary product is the AliveCor KardiaMobile, a portable ECG device that can be used to detect atrial fibrillation (AFib) and other cardiac conditions. AliveCor was founded in 2010 and is headquartered in Mountain View, California, the United States.
CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and vital signs monitoring. CardiacSense is based in Caesarea, Israel.
A pulse watch, also known as a pulsometer or pulsograph, is an individual monitoring and measuring device with the ability to measure heart or pulse rate. Detection can occur in real time or can be saved and stored for later review. The pulse watch measures electrocardiography data while the user is performing tasks, whether it be simple daily tasks or intense physical activity. The pulse watch functions without the use of wires and multiple sensors. This makes it useful in health and medical settings where wires and sensors may be an inconvenience. Use of the device is also common in sport and exercise environments where individuals are required to measure and monitor their biometric data.
A coronavirus breathalyzer is a diagnostic medical device enabling the user to test with 90% or greater accuracy the presence of severe acute respiratory syndrome coronavirus 2 in an exhaled breath. As of the first half of 2020, the idea of a practical coronavirus breathalyzer was concomitantly developed by unrelated research groups in Australia, Canada, Finland, Germany, Indonesia, Israel, Netherlands, Poland, Singapore, United Kingdom and USA.
Esther Rodriguez-Villegas is a Spanish engineer, inventor and the Professor of Low Power Electronics at Imperial College London. Rodriguez-Villegas develops lightweight, low-power electronic devices for real-time monitoring of physiological signals. She was awarded the 2020 Royal Academy of Engineering Silver Medal for her work on wearable medical devices. In 2020, she was elected a Fellow of the Royal Academy of Engineering.
BioSerenity is medtech company created in 2014 that develops ambulatory medical devices to help diagnose and monitor patients with chronic diseases such as epilepsy. The medical devices are composed of medical sensors, smart clothing, a smartphone app for Patient Reported Outcome, a web platform to perform data analysis through Medical Artificial Intelligence for detection of digital biomarkers. The company initially focused on Neurology, a domain in which it reported contributing to the diagnosis of 30 000 patients per year. It now also operates in Sleep Disorders and Cardiology. BioSerenity reported it provides pharmaceutical companies with solutions for companion diagnostics.